NCT01329939 The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics Status COMPLETED Phase NA
NCT01329913 Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003) Status COMPLETED Phase PHASE1
NCT01326559 Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) Status COMPLETED Phase PHASE2
NCT01325662 A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211) Status COMPLETED Phase N/A
NCT01325051 Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01324726 Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms Status COMPLETED Phase N/A
NCT01324440 Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002) Status COMPLETED Phase PHASE1
NCT01323855 A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512) Status COMPLETED Phase PHASE1
NCT01321476 Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis Status WITHDRAWN Phase N/A
NCT01319383 The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART Status COMPLETED Phase PHASE1/PHASE2
NCT01318382 Residual Curarization and Its Incidence at Tracheal Extubation (P08194) Status COMPLETED Phase PHASE4
NCT01318148 Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis Status COMPLETED Phase PHASE2
NCT01315847 Positron Emission Tomography (PET) Study of Brain Calcitonin Gene-Related Peptide (CGRP) Receptor Occupancy After Telcagepant Administration (MK-0974-067) Status COMPLETED Phase PHASE1
NCT01314872 A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008) Status COMPLETED Phase PHASE2